Michael Tees, MD, MPH, Colorado Blood Cancer Institute, Denver, CO
Category Archives: CAR T-cell Therapy
Highlights from attending the 2023 ASH Annual Meeting
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
CAR T-cell Therapy in Review 2022: Updates in Treatment
Sattva S. Neelapu, MD, M.D. Anderson Cancer Center, Houston, TX
CAR T-cell Therapy in 2022: What You Need to Know Part II
Rayne H. Rouce, MD, BS, Texas Children’s Cancer Center for Cell and Gene Therapy, Houston, TX
CAR T-cell Therapy in 2022: What You Need to Know
Caron Jacobson, MD, Dana-Farber Cancer Institute, Boston, MA
Highpoints from Attending the 2021 American Society of Hematology Conference
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY